EUVIMEDOpdag EUVIMED
Crossref

A Metal–Organic Nanoplatform Coassembled with Artesunate and Chlorin e6 for Synergistic Chemo/Photodynamic Cancer Therapy

Ling Yang, Hailin Shen, Yigang Wang, Gang Cui, Nan Su, Yan Zhang iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202501003 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Ling Yang and 5 co-authors. Institution: Department of Nuclear Medicine, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou, China. Major MEDLINE topics: Porphyrins, Photochemotherapy, Artesunate, Antineoplastic Agents. Cited 1 times so far (Crossref); 33 references. Funded by: Suzhou Municipal Health Commission.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Antitumor efficacy based on conventional chemodynamic therapy (CDT) is frequently constrained by insufficient endogenous H 2 O 2 and the limitations of monotherapy. Herein, we developed a metal‐organic nanoplatform (CA‐Fe NPs). This platform was fabricated through Fe 3+ ‐driven coordination assembly of artesunate (AS) and chlorin e6 (Ce6), facilitating preferential tumor accumulation via the enhanced permeability and retention (EPR) effect. Upon cellular internalization and 660 nm laser irradiation, the nanodrug enables a synergistic combination of Ce6‐mediated photodynamic therapy (PDT) and AS‐induced oxidative stress, which collaboratively amplifies intracellular reactive oxygen species (ROS) generation. This cascade induces mitochondrial membrane potential collapse, leading to extensive apoptotic cell death (77.5%). In a 4T1 tumor‐bearing mouse model, this approach achieved marked tumor suppression with an excellent safety profile, offering a promising strategy for combination therapy.

Subjects

MeSH terms (MEDLINE)

PorphyrinsPhotochemotherapyArtesunateAntineoplastic AgentsPhotosensitizing AgentsMetal-Organic FrameworksChlorophyllidesAnimalsMiceReactive Oxygen SpeciesHumansApoptosisDrug Screening Assays, AntitumorMice, Inbred BALB CDose-Response Relationship, DrugCell SurvivalStructure-Activity RelationshipFemaleCell ProliferationCell Line, TumorMolecular StructureMembrane Potential, Mitochondrial

Author keywords

chemodynamic therapycombination therapyphotodynamic therapyreactive oxygen speciessynergistic effect

Substances

ChlorophyllidesphytochlorinPorphyrinsArtesunateAntineoplastic AgentsReactive Oxygen SpeciesPhotosensitizing AgentsMetal-Organic Frameworks

Authors and institutions

  • Department of Nuclear Medicine, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou, China.
  • Department of Radiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, China.
  • The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Sports Teaching and Research Office, Suzhou Institute of Trade and Commerce, Suzhou, China.
  • The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.

ORCID profiles: Yan Zhang

Funding

  • Suzhou Municipal Health Commission

Cite

APA

Yang, L., Shen, H., Wang, Y., Cui, G., Su, N., & Zhang, Y. (2026). A Metal–Organic Nanoplatform Coassembled with Artesunate and Chlorin e6 for Synergistic Chemo/Photodynamic Cancer Therapy. ChemMedChem. https://doi.org/10.1002/cmdc.202501003

Vancouver

Yang L, Shen H, Wang Y, Cui G, Su N, Zhang Y. A Metal–Organic Nanoplatform Coassembled with Artesunate and Chlorin e6 for Synergistic Chemo/Photodynamic Cancer Therapy. ChemMedChem. 2026. doi:10.1002/cmdc.202501003

BibTeX
@article{Yang2026,
  author = {Yang, Ling and Shen, Hailin and Wang, Yigang and Cui, Gang and Su, Nan and Zhang, Yan},
  title = {A Metal–Organic Nanoplatform Coassembled with Artesunate and Chlorin e6 for Synergistic Chemo/Photodynamic Cancer Therapy},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202501003}
}
Start for free →